Kyndryl Posts 2Q EPS of 27 Cents
KD sits 39% above its 52-week low of $10.1.
Summary
Kyndryl reported second-quarter net income of $59 million and adjusted earnings per share of 42 cents, with revenue of $3.65 billion, down 1.9% year-over-year. Adjusted EBITDA came in at $699 million, and the results included $38 million in workforce rebalancing charges. That marks a swing from Q1 FY2027, which was a $55 million net loss on $3.62 billion of revenue, down 3% year-over-year, weighed down by $152 million in restructuring charges. The company said strong signings and continued growth in Kyndryl Consult and hyperscaler-related revenue reinforce its confidence in its fiscal 2027 outlook, and it sees FY27 free cash flow of $400 million-$500 million. On the deal front, the Healthcare IT Leaders acquisition was announced in August and a 10-year U.S. government IT modernization contract came in September, alongside a $1 billion senior notes refinancing that closed in late September.
At the time of this announcement, KD was trading at $14.05 on NYSE in the Technology sector, with a market capitalization of approximately $2.8B. The 52-week trading range was $10.10 to $29.45. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.